What is the ticker symbol for Altamira Therapeutics?

Altamira Therapeutics trades under the ticker CYTO on NASDAQ.

What sector does Altamira Therapeutics operate in?

Altamira Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CYTO in a portfolio?

PortView shows CYTO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Altamira Therapeutics (CYTO) Stock Analysis

NASDAQHealthcareBiotechnology

$0.30+100.00%

1-year price historyRange $0.05 – $2.42

52-week range$0.30

$0.30$0.42

What Altamira Therapeutics does

Altamira Therapeutics Ltd. is a biotechnology firm dedicated to pioneering new treatments for critical medical needs that are currently underserved. Its marketed offerings include Bentrio, a non-pharmaceutical nasal spray designed for individual protection against prevalent airborne viruses and allergens. The company is also heavily invested in developing RNA therapeutics specifically for extrahepatic targets. This includes their preclinical OligoPhore and SemaPhore platforms, engineered for the effective delivery of oligonucleotides and mRNA. In its clinical-stage portfolio, AM-125 is undergoing Phase II trials for the intranasal treatment of vertigo. Additionally, Keyzilen and Sonsuvi are both in Phase III clinical development; Keyzilen is focused on acute inner ear tinnitus, and Sonsuvi addresses acute inner ear hearing loss. Established in 2003 and headquartered in Hamilton, Bermuda, Altamira Therapeutics conducts operations across Switzerland, the United States, Europe, and Australia. The company officially adopted the name Altamira Therapeutics Ltd. in July 2021, prior to which it was known as Auris Medical Holding Ltd.

Key metrics

Market cap

$1.13M

P/E (TTM)

0.16

EPS (TTM)

$1.82

Beta

2.44

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$0.17

200-day avg

$0.60

52-week high

$0.42

52-week low

$0.30

CEO

Thomas Meyer

ETFs linked to CYTO

Broad-market and Healthcare sector ETFs an investor holding Altamira Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CYTO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CYTO in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Altamira Therapeutics?: Altamira Therapeutics trades under the ticker CYTO on NASDAQ.
Which exchange is CYTO listed on?: CYTO is listed on NASDAQ.
What sector does Altamira Therapeutics operate in?: Altamira Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CYTO in a portfolio?: PortView shows CYTO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.